Latest stories on BFRI
Biofrontera Gains FDA Approval for Ameluz Skin Cancer Use
TipRanks76 · bullishproduct/pr
Biofrontera announces FDA approval of Ameluz supplemental new drug application
The Fly78 · bullishproduct/pr
Biofrontera Inc. (BFRIW) files 8-K
SEC 8-K50 · neutralgeneral
Biofrontera Announces FDA Approval of Ameluz® Red Light PDT for the Treatment of Superficial Basal Cell Carcinoma
StockTitan78 · bullishproduct/pr
Biofrontera Announces FDA Approval of Ameluz® Red Light PDT for the Treatment of Superficial Basal Cell Carcinoma
GlobeNewswire78 · bullishproduct/pr
FDA approves label update for Biofrontera’s Ameluz Gel
The Fly73 · bullishproduct/pr
Biofrontera (BFRI) Q2 2026 Earnings Call Transcript
Yahoo Finance67 · bullishearnings
Biofrontera (BFRI) Q2 2026 Earnings Call Transcript
The Motley Fool67 · bullishearnings
Biofrontera outlines September 28, 2026 PDUFA date and expects sBCC launch in Q1 2027 amid ITC lamp remediation
Seeking Alpha63 · neutralproduct/pr
Biofrontera Inc. (BFRI) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Biofrontera GAAP EPS of -$0.05, revenue of $12M
Seeking Alpha56 · neutralearnings
Biofrontera Inc. (BFRIW) files 8-K
SEC 8-K50 · neutralgeneral
Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth
StockTitan67 · bullishearnings
Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth
GlobeNewswire68 · bullishearnings
Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026
StockTitan50 · neutralgeneral
Biofrontera’s Phase III Actinic Keratosis Study Nears Data Payoff for Investors
TipRanks67 · bullishproduct/pr
Biofrontera Inc. (BFRIW) files 8-K
SEC 8-K50 · neutralgeneral
Biofrontera Inc. (BFRI) Shareholder/Analyst Call Prepared Remarks Transcript
Seeking Alpha50 · neutralgeneral
Biofrontera Earnings Call Highlights Growth And Risks
TipRanks56 · neutralearnings
Biofrontera (BFRI) Q1 2026 Earnings Transcript
Yahoo Finance50 · neutralearnings
Biofrontera targets cash flow breakeven in 2026 while aiming for 80%-85% gross margin
Seeking Alpha67 · bullishgeneral
Biofrontera Inc. (BFRI) Q1 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings